EstroMend

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for EstroMend
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetarian Capsule(s)
Serving Size
30
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

EstroMend A Phytocrine Proprietary Blend
2780 mg
EstroMend A Phytocrine Proprietary Blend
1390 mg
Market median: 80.0mg (136 products)
Market median: 80.0mg (136 products)

Other Ingredients

Hydroxypropyl Methylcellulose Vegetable Stearate Silica Microcrystalline Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 2-4 capsules daily or as directed by your health professional.

Warnings & Precautions

Warning: Not to be taken by pregnant or lactating women. If you have any health condition, particularly a liver condition, or are taking any medication, consult your health professional before use.

Keep out of the reach of children.

Your health professional may decide to monitor liver function while taking this product. Use only if safety seal is intact.

Formulation Notes

Gluten-free, Non-GMO

Hormone specific formulation

Healthy estrogen metabolism and function

Additional Information

Store in a cool, dry place.

Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity. Scan to learn about our manufacturing excellence

Metadata

Product Details

UPC / SKU3 10539 03871 0
DSLD Entry Date2022-09-22
Product TypeBotanical
FormCapsule
DSLD ID274065
Data Updated2026-04-11
Research

Research Evidence

31
Research Sources
49
Avg Quality
23
Systematic Review
5
Meta Analysis
1
Rct
1
Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020 PubMed
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017 PubMed DOI
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011 PubMed DOI
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021 PubMed DOI
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010 PubMed
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023 PubMed DOI
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010 PubMed
View all evidence for Black Cohosh →
Compare

Similar Products

View all Black Cohosh products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.